Cancer clinical trial participation: a qualitative study of Black/African American communities' and patient/survivors' recommendations.

ABSTRACT:

Background

Black/African Americans experience disproportionate cancer burden and mortality rates. Racial and ethnic variation in cancer burden reflects systemic and health-care inequities, cancer risk factors, and heredity and genomic diversity. Multiple systemic, sociocultural, economic, and individual factors also contribute to disproportionately low Black/African American participation in cancer clinical trials.

Methods

The Participatory Action for Access to Clinical Trials project used a community-based participatory research approach inclusive of Black/African American community-based organizations, Henry Ford Health, and the University of Michigan Urban Research Center. The project aims were to understand Black/African Americans' behavioral intentions to participate in

SUBMITTER: Kaljee L 

PROVIDER: S-EPMC11781321 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature